サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1551731

糖尿病眼疾患機器の世界市場

Diabetic Eye Disease Devices

出版日
ページ情報
英文 270 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
糖尿病眼疾患機器の世界市場
出版日: 2024年09月10日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 270 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

糖尿病眼疾患機器の世界市場は2030年までに16億米ドルに到達

2023年に10億米ドルと推定される糖尿病眼疾患機器の世界市場は、分析期間2023-2030年にCAGR 6.2％で成長し、2030年には16億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである硝子体手術は、CAGR 6.4％を記録し、分析期間終了までに12億米ドルに達すると予測されます。レーザー手術セグメントの成長率は、分析期間でCAGR 5.7％と推定されます。

米国市場は2億7,950万米ドルと推定、中国はCAGR10.1％で成長予測

米国の糖尿病眼疾患機器市場は2023年に2億7,950万米ドルと推定されます。世界第2位の経済大国である中国は、2023-2030年のCAGRを10.1%として、2030年までに3億3,750万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ2.6%と6.3%と予測されています。欧州では、ドイツがCAGR 3.9%で成長すると予測されています。

世界の糖尿病眼疾患機器市場- 主要動向と促進要因のまとめ

糖尿病眼疾患機器とは何か、なぜ必要なのか？

糖尿病眼疾患機器は、糖尿病性網膜症、糖尿病性黄斑浮腫、白内障、緑内障など、糖尿病に関連する眼の状態を診断、監視、治療するために設計された特殊な医療ツールおよび技術です。これらの疾患は、速やかに発見・管理されなければ、重度の視力障害や失明に至ることもあります。糖尿病眼疾患機器は、これらの疾患の早期発見と継続的な管理に重要な役割を果たしており、糖尿病性眼疾患の進行性を考えると、これは極めて重要です。糖尿病眼疾患機器は、糖尿病性眼疾患の進行性を考慮すると極めて重要です。これらの装置の重要性は、視力が著しく低下するまで患者が気づかないような微小動脈瘤や出血などの網膜障害の初期徴候を識別する能力にあります。タイムリーな介入を可能にすることで、これらの機器は糖尿病眼疾患の予防や進行を遅らせるのに役立ち、それによって視力を維持し、患者の生活の質を向上させる。糖尿病の世界の有病率が上昇を続ける中、効果的で信頼性の高い糖尿病眼疾患機器の需要は、糖尿病に関連する失明との闘いにおいてこれまで以上に重要になっています。

技術の進歩はどのように糖尿病眼疾患機器を強化しているのでしょうか？

技術の進歩は、糖尿病眼疾患機器の有効性、正確性、アクセシビリティを著しく向上させています。光干渉断層計（OCT）や眼底写真などの最新の診断ツールは、網膜の高解像度画像を提供し、眼の内部構造の詳細な検査を可能にします。これらの技術は、病気の進行を示す網膜の微細な変化を臨床医が識別できるようにすることで、糖尿病網膜症や黄斑浮腫の早期発見に革命をもたらしました。さらに、これらの機器に人工知能（AI）と機械学習アルゴリズムを統合することで、診断の精度と効率がさらに向上しました。AIを搭載した網膜スクリーニング・ツールは、糖尿病性眼疾患の兆候を高い精度で画像解析することができ、多くの場合、人間の専門家の性能に匹敵するか、それを上回ることさえあります。この技術は、眼科医へのアクセスが制限されている遠隔地や十分なサービスを受けていない地域では特に価値があります。さらに、汎網膜光凝固や集光レーザー治療で使用されるようなレーザー治療装置の進歩は、治療介入の精度と安全性を向上させ、合併症のリスクを減らし、患者の転帰を向上させています。このような技術的改良は、糖尿病眼疾患機器をより効果的にするだけでなく、より多くの患者がタイムリーで適切な治療を受けられるよう、その利用可能性と使いやすさを向上させています。

なぜ患者やヘルスケアプロバイダーは糖尿病眼疾患機器を受け入れているのか？

糖尿病眼疾患機器の患者およびヘルスケアプロバイダーによる採用が増加している背景には、糖尿病に関連する眼疾患の負担増を管理する差し迫った必要性があります。患者にとって、これらのデバイスは目の健康への積極的なアプローチを提供し、定期的なモニタリングと、重大な視力低下につながる前に潜在的な問題を早期に発見することを可能にします。また、網膜画像やOCTスキャンなど、非侵襲的な診断検査の利便性により、患者は不快感や長時間の処置を受けることなく、定期的な検診を受けやすくなります。さらに、糖尿病性眼疾患に関連するリスクに対する認識が高まり、高度なスクリーニング技術が利用できるようになったことで、糖尿病管理計画の一環として定期的な眼科検診を受ける患者が増加しています。ヘルスケアプロバイダーにとって、糖尿病眼疾患機器は糖尿病患者の眼の状態を診断し、その進行を追跡するための信頼できる効率的な手段を提供します。網膜の微妙な変化を早期に発見する能力により、重篤な合併症を予防するタイムリーな介入が可能になり、最終的に患者の転帰を改善することができます。さらに、これらの機器にAIや遠隔医療ソリューションが統合されたことで、特に眼科サービスが乏しい地域では専門的な治療へのアクセスが拡大し、これらの機器は現代の糖尿病管理に不可欠なツールとなっています。

糖尿病眼疾患機器市場の成長を促進する要因は？

糖尿病眼疾患機器市場の成長は、糖尿病の世界の有病率の増加と合併症の効果的な管理の必要性を反映するいくつかの重要な要因によって牽引されています。主な要因のひとつは、世界の糖尿病罹患率の上昇であり、特に高齢化社会と肥満率が高く、座りがちな生活習慣が多い地域で顕著です。糖尿病と診断される人が増えるにつれて、関連する眼の状態をモニターし治療できる機器に対する需要が急増しています。高解像度の画像システム、AIを搭載した診断ツール、より精密なレーザー治療の開発など、技術の進歩も市場の拡大に重要な役割を果たしています。これらの技術革新により、糖尿病眼科治療の精度、安全性、アクセシビリティが向上し、より早期かつ効果的な診断と治療が可能になった。また、予防ヘルスケアと早期発見が重視されるようになり、スクリーニング・プログラムへの投資が拡大し、日常診療に糖尿病眼疾患機器が採用されるようになったことも、市場成長を促す大きな要因となっています。さらに、新興市場におけるヘルスケア・インフラの拡大や、糖尿病による失明と闘うための政府の取り組みが、これらの機器の需要をさらに押し上げています。最後に、定期的な眼科検診の重要性に対する患者の意識の高まりと、高度な診断オプションの利用可能性が、市場の継続的な拡大に寄与しており、糖尿病眼疾患機器が今後も糖尿病治療の重要な要素であり続けることを保証しています。

調査対象企業の例（全36件）

  • Aaren Scientific Inc.
  • Alcon Inc.
  • Bausch+Lomb
  • Carl Zeiss Meditec AG
  • CooperVision, Inc.
  • Essilor International S.A.
  • IRIDEX Corporation
  • Johnson & Johnson Innovative Medicine
  • Lumenis Be Ltd.
  • Nidek Co., Ltd.
  • Novartis AG
  • STAAR Surgical Company
  • Stryker Corporation;

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP26707

Global Diabetic Eye Disease Devices Market to Reach US$1.6 Billion by 2030

The global market for Diabetic Eye Disease Devices estimated at US$1.0 Billion in the year 2023, is expected to reach US$1.6 Billion by 2030, growing at a CAGR of 6.2% over the analysis period 2023-2030. Vitrectomy, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$1.2 Billion by the end of the analysis period. Growth in the Laser Surgery segment is estimated at 5.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$279.5 Million While China is Forecast to Grow at 10.1% CAGR

The Diabetic Eye Disease Devices market in the U.S. is estimated at US$279.5 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$337.5 Million by the year 2030 trailing a CAGR of 10.1% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.6% and 6.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.

Global Diabetic Eye Disease Devices Market - Key Trends and Drivers Summarized

What Are Diabetic Eye Disease Devices and Why Are They Essential?

Diabetic eye disease devices are specialized medical tools and technologies designed to diagnose, monitor, and treat eye conditions associated with diabetes, such as diabetic retinopathy, diabetic macular edema, cataracts, and glaucoma. These conditions can lead to severe vision impairment or even blindness if not detected and managed promptly. Diabetic eye disease devices play a crucial role in the early detection and ongoing management of these conditions, which is vital given the progressive nature of diabetic eye diseases. The importance of these devices lies in their ability to identify early signs of retinal damage, such as microaneurysms or hemorrhages, that might not be noticeable to the patient until significant vision loss has occurred. By enabling timely interventions, these devices help prevent or slow the progression of diabetic eye diseases, thereby preserving vision and improving the quality of life for patients. As the global prevalence of diabetes continues to rise, the demand for effective and reliable diabetic eye disease devices has become more critical than ever in the fight against diabetes-related blindness.

How Are Technological Advances Enhancing Diabetic Eye Disease Devices?

Technological advancements have significantly enhanced the effectiveness, accuracy, and accessibility of diabetic eye disease devices. Modern diagnostic tools, such as optical coherence tomography (OCT) and fundus photography, provide high-resolution images of the retina, allowing for detailed examination of the eye's internal structures. These technologies have revolutionized the early detection of diabetic retinopathy and macular edema by enabling clinicians to identify minute changes in the retina that might indicate disease progression. Additionally, the integration of artificial intelligence (AI) and machine learning algorithms into these devices has further improved diagnostic accuracy and efficiency. AI-powered retinal screening tools can analyze images for signs of diabetic eye disease with a high degree of accuracy, often matching or even surpassing the performance of human experts. This technology is particularly valuable in remote or underserved areas, where access to ophthalmologists may be limited. Moreover, advancements in laser therapy devices, such as those used in panretinal photocoagulation or focal laser treatments, have improved the precision and safety of therapeutic interventions, reducing the risk of complications and enhancing patient outcomes. These technological improvements not only make diabetic eye disease devices more effective but also increase their availability and usability, helping more patients receive timely and appropriate care.

Why Are Patients and Healthcare Providers Embracing Diabetic Eye Disease Devices?

The growing adoption of diabetic eye disease devices by both patients and healthcare providers is driven by the pressing need to manage the rising burden of diabetes-related eye conditions. For patients, these devices offer a proactive approach to eye health, enabling regular monitoring and early detection of potential issues before they lead to significant vision loss. The convenience of non-invasive diagnostic tests, such as retinal imaging and OCT scans, also makes it easier for patients to undergo regular check-ups without discomfort or lengthy procedures. Additionally, the increasing awareness of the risks associated with diabetic eye disease, combined with the availability of advanced screening technologies, has encouraged more patients to seek regular eye care as part of their diabetes management plan. For healthcare providers, diabetic eye disease devices provide a reliable and efficient means of diagnosing and tracking the progression of eye conditions in diabetic patients. The ability to detect subtle retinal changes early on allows for timely interventions that can prevent severe complications, ultimately improving patient outcomes. Furthermore, the integration of AI and telemedicine solutions into these devices has expanded access to specialized care, particularly in regions where ophthalmology services are scarce, making these devices an indispensable tool in modern diabetes management.

What Factors Are Driving the Growth of the Diabetic Eye Disease Devices Market?

The growth in the diabetic eye disease devices market is driven by several key factors that reflect the increasing global prevalence of diabetes and the need for effective management of its complications. One of the primary drivers is the rising incidence of diabetes worldwide, particularly in aging populations and regions with high rates of obesity and sedentary lifestyles. As more people are diagnosed with diabetes, the demand for devices that can monitor and treat associated eye conditions has surged. Technological advancements, including the development of high-resolution imaging systems, AI-powered diagnostic tools, and more precise laser therapies, have also played a crucial role in expanding the market. These innovations have improved the accuracy, safety, and accessibility of diabetic eye care, making it possible to diagnose and treat conditions earlier and more effectively. Another significant factor driving market growth is the increasing emphasis on preventive healthcare and early detection, which has led to greater investment in screening programs and the adoption of diabetic eye disease devices in routine clinical practice. Additionally, the expansion of healthcare infrastructure in emerging markets, along with government initiatives to combat diabetes-related blindness, has further fueled the demand for these devices. Lastly, the growing awareness among patients about the importance of regular eye exams and the availability of advanced diagnostic options has contributed to the market's continued expansion, ensuring that diabetic eye disease devices will remain a critical component of diabetes care in the years to come.

Select Competitors (Total 36 Featured) -

  • Aaren Scientific Inc.
  • Alcon Inc.
  • Bausch + Lomb
  • Carl Zeiss Meditec AG
  • CooperVision, Inc.
  • Essilor International S.A.
  • IRIDEX Corporation
  • Johnson & Johnson Innovative Medicine
  • Lumenis Be Ltd.
  • Nidek Co., Ltd.
  • Novartis AG
  • STAAR Surgical Company
  • Stryker Corporation;

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Diabetic Eye Disease Devices - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Diabetes Expands Addressable Market Opportunity for Diabetic Eye Care
    • Advancements in Diagnostic Imaging Propel Growth in Diabetic Eye Disease Devices
    • Integration of AI and Machine Learning Strengthens the Business Case for Early Detection and Monitoring
    • Growing Focus on Preventive Healthcare Drives Adoption of Early Detection and Monitoring Tools
    • Innovations in Non-Invasive Testing Spur Growth in Diabetic Eye Disease Management
    • Increasing Awareness of Diabetic Retinopathy and Other Complications Generates Demand for Screening Devices
    • Expanding Healthcare Access Create New Growth Avenues for Diabetic Eye Disease Devices
    • Focus on Patient Compliance and User-Friendly Designs Sustains Growth in Home Monitoring Solutions
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Diabetic Eye Disease Devices Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Diabetic Eye Disease Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Diabetic Eye Disease Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Vitrectomy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Vitrectomy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Vitrectomy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Laser Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Laser Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Laser Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Ophthalmic Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Ophthalmic Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Ophthalmic Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Diabetic Eye Disease Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: USA 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 23: USA Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: Canada 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • JAPAN
    • Diabetic Eye Disease Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: Japan 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • CHINA
    • Diabetic Eye Disease Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: China 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 41: China Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: China 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • EUROPE
    • Diabetic Eye Disease Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Diabetic Eye Disease Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: Europe 16-Year Perspective for Diabetic Eye Disease Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • FRANCE
    • Diabetic Eye Disease Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 53: France Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: France 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: France 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • GERMANY
    • Diabetic Eye Disease Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: Germany 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: Italy 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Diabetic Eye Disease Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 71: UK Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: UK 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: Spain 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Russia 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Rest of Europe 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Diabetic Eye Disease Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Diabetic Eye Disease Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Asia-Pacific 16-Year Perspective for Diabetic Eye Disease Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Diabetic Eye Disease Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: Australia 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • INDIA
    • Diabetic Eye Disease Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 110: India Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: India 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 113: India Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 115: India 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 118: South Korea 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Diabetic Eye Disease Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Diabetic Eye Disease Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 130: Latin America 16-Year Perspective for Diabetic Eye Disease Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 139: Argentina 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 145: Brazil 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 151: Mexico 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 157: Rest of Latin America 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Diabetic Eye Disease Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Diabetic Eye Disease Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 163: Middle East 16-Year Perspective for Diabetic Eye Disease Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 172: Iran 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 178: Israel 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 184: Saudi Arabia 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 190: UAE 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 196: Rest of Middle East 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • AFRICA
    • Diabetic Eye Disease Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 202: Africa 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030

IV. COMPETITION